Cardiometabolic Disease
7
3
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
HomeStyles-Adults of Chinese Heritage
Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity
Building Access to Food Through Systems and Solidarity (BASIS): A Subsidized and Culturally-adapted Produce Box Program for Immigrant Communities of Brooklyn, NY
The Impact of Faba Bean Rich Bread on Iron Status, Postprandial Lipaemia and Satiety
Telehealth Integrated Care Model in Patients With Cardiometabolic Disease
A Feasibility Study of a Health Coaching Programme for Middle-aged Adults With Cardiometabolic Risk
Metagenomics and Integrative Systems Medicine of Cardiometabolic Diseases